A project with an up-front com at t = 0 of $1500 is being considered by a startup pharmaceutical company. (All dollars in this problem are in thousands.) The project's subsequent cash flow are critically dependant on whether a competitor's product is approved by the food and Drug Administration. If the FDA rejects the competitive product, the startup's product will have high sales and cash flows, but If the competitive product is approved, that will negative impact the cash flows There is a 75% chance that the competitive product will be rejected, in which case the startup's expected cash flows will be $500 at the end of each of the next seven years (t = 1 to 7). There is a 25% chance that the competitor's product will be approved, in which case the expected cash flows will be only $25 at the end of each of the next seven years (t = 1 to 7). NPC will know for sure one year from today whether the competitor' product has been approved. The startup is considering whether to make the investment today or to wait a year to find out about the FDA's decision. If it waits a year, the project's up-front cost at t = 1 will remain at $1, 500, the subsequent cash flows will remain at $500 per year if the competitor's product is rejected and $25 per year If the alternative product is approved. However, if the startup decides to wait, the subsequent cash flows will be received only for six years (t = 2 ... 7). Assuming that all cash flows are discounted at 10%, if the startup chooses to wait a year before proceeding, how much will this increase or decrease the project's expected NPV in today's (i.e., at t = 0), relative to the NPV if it proceeds today